We are live on
!
Find out more
SLG
Silver Lake Group Portfolio holdings
AUM
$4.58B
1-Year Est. Return
24.86%
This Fund
S&P 500
This Quarter
Est. Return
+2.28%
1 Year Est. Return
+24.86%
3 Year Est. Return
+82.84%
5 Year Est. Return
+66.9%
10 Year Est. Return
+727.54%
AUM
$5.03B
AUM Growth
-$105M
(-2%)
Cap. Flow
-$160M
Cap. Flow
% of AUM
-3.19%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
13
New
–
Increased
–
Reduced
–
Closed
2
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CAI
Caris Life Sciences
CAI
|
+$160M |
| 2 |
Realty Income
O
|
+$208K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 55.84% |
| 2 | Industrials | 25.87% |
| 3 | Communication Services | 9.77% |
| 4 | Financials | 8.32% |
| 5 | Healthcare | 0.19% |
Similar funds
LP
CSP
MR
BWA
FLSM
AF
CCA
AT
Silver Lake Group's Q4 2025 Portfolio in Review
As of Q4 2025, Silver Lake Group held 13 positions worth $5.03B, down 2% from $5.13B the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Silver Lake Group withdrew a net $160M in Q4 2025, closing 2 positions. Its most notable exit was Caris Life Sciences, an estimated $160M position sold in full.
By sector, the portfolio is most concentrated in Technology at 56% of assets, up from 51% a quarter earlier, followed by Industrials and Communication Services.
- Silver Lake Group fully exited Caris Life Sciences in Q4 2025, selling an estimated $160M.
- Silver Lake Group's ten largest holdings make up 100% of its $5.03B portfolio in Q4 2025.
- Silver Lake Group opened 0 new positions and closed 2 in Q4 2025.
- Silver Lake Group's portfolio value fell 2% quarter-over-quarter to $5.03B.
Based on Silver Lake Group's 13F filing for Q4 2025, filed 13 Feb 2026.